|
|
|
市場調查報告書
特殊酵素的全球市場
Specialty Enzymes
|
特殊酵素的全球市場 是由出版商Global Industry Analysts, Inc.在2010年10月所出版的。
這份英文市場調查報告書包含Pages: 274 價格從美金4500起跳。
本報告書以特殊酵素為焦點，對其種類與機能、用途、技術等進行整理之餘，並提供世界市場現況與發展機會、課題等關於將來的動向進行分析・預測等最新調査資料，概述如下。
目次
第1章 導論、方法論、產品定義
第2章 世界市場概要
第3章 酵素 - 檢驗
第4章 特殊酵素：概要
第5章 消費市場分析
第6章 技術動向
- 蛋白質工學技術
- 產業用途的特殊酵素
- 養豬業的酵素技術
第7章 產品導入・開發
第8章 產品開發・導入最新情報 - 代表事例集
第9章 最近業界動向
第10章 企業動向最新情報 - 代表事例集
第11章 全球主要企業
第12章 世界市場前景
第13章 美國
第14章 加拿大
第15章 日本
第16章 歐洲
- 法國
- 德國
- 義大利
- 英國
- 西班牙
- 俄羅斯
- 其他國家
第17章 亞太地區
第18章 中東
第19章 中南美
競爭環境
Abstract
This report analyzes the worldwide markets for Specialty Enzymes in US$
Million by the following product segments - Specialty Medical Enzymes,
Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use
segments discussed are Pharmaceuticals & Diagnostics, and
Research/Biotechnology. The report provides separate comprehensive analytics
for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin
America. Annual estimates and forecasts are provided for the period 2007
through 2015. A seven-year historic analysis is also provided for these
markets.The report profiles 44 companies including many key and niche players
such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme
Inc., Biocon Ltd., Biozyme Laboratories Limited, Danisco A/S, Genencor
International, Inc., Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc.,
Novozymes A/S, Seravac Biotech (Pty) Ltd, Specialty Enzymes & Biochemicals
Co., and Verenium Corporation. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
Table of Contents
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability And Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions And Scope Of Study
- Specialty Medical Enzymes
- Polymerases
- Nucleases
- Other Specialty Enzymes
- Pharmaceuticals/Diagnostic
- Research/Biotechnology
2. GLOBAL MARKET OVERVIEW
- Current and Future Analysis
- Recession Derails the Market Momentum
- Competitive Scenario
- Table 1: Leading Players in the Global Enzyme Market(2009):
Percentage Breakdown of Value Sales forNovozymes, Danisco, Genzyme, Roche,
Allergan, DSMand Others (includes corresponding Graph/Chart)
3. ENZYMES - A REVIEW
- Definition
- Introduction
- Advantages of Enzymes Compared to Chemical Catalysts
- A Brief History
4. SPECIALTY ENZYMES: AN OVERVIEW
- Analysis of Product Segments
- Specialty Medical Enzymes
- Polymerases
- Nucleases
- Other Specialty Enzymes
5. ANALYSIS OF THE END-USE MARKETS
- Pharmaceuticals & Diagnostics
- Research/Biotechnology
- Other End Use Markets
6. TECHNOLOGY TRENDS
- Protein Engineering Technology
- Specialty Enzymes in Industrial Uses
- Enzyme Technology in Pig Industry
7. PRODUCT INTRODUCTIONS/INNOVATIONS
- Verenium Launches Xylathin
- Novagen Introduces Novagen® KOD XtremeTM
- Hot Start DNA Polymerase Kit
- Verenium Launches New Veretase High-Performance Enzyme
8. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER
- MARDI Develops Taq DNA Polymerase
- Stratagene Corporation Commercializes DNA Polymerases
- Takara Bio Launches PrimeSTAR HS DNA Polymerase
9. RECENT INDUSTRY ACTIVITY
- Thermo Fisher Scientific Acquires Finnzymes
- Verenium and Add Food Service Enter into an Agreement
- Verenium and Syngenta End Collaborative Research Program
- Verenium Collaborates with Alfa Laval for Purifine PLC Enzyme
- Verenium and Bunge Enter into an Agreement for Enzyme Process Development
- Inverness Medical Innovations Acquires BBI Holdings Plc
- Helix Biopharma Enters into a Contract with KBI Biopharma
- Verenium Enters into Agreement with Bunge Oils
10. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER
- BBI Holdings Acquires Theratase Plc
- Danisco to Acquire Stake in South African Firm
- Affymetrix to Buy USB Corporation
- Diversa Merges with Celunol to Form Verenium Corporation
- Diversa Collaborates with BASF
- Codexis Expands Collaboration with Royal Dutch Shell to Develop Super
Enzymes
- Diversa Enters into a Deal with Syngenta to Develop Enzymes
- Genencor Begins Operation at New China Site and Introduces a New Detergent
Enzyme
- Verenium Receives $4.6 million For Enzyme Development
- Biocon Divests its Enzymes Business to Novozymes
- Solexa Signs Agreement with New England Biolabs
- Danisco Takes Over Genencor
- IBEX Technologies Inks Agreement with Cape Cod and Prozyme
11. FOCUS ON SELECT GLOBAL PLAYERS
- Advanced Enzymes Technologies Limited (India)
- Amano Enzyme, Inc. (Japan)
- Aureozyme, Inc. (US)
- Biocon Ltd. (India)
- Biozyme Laboratories Limited (UK)
- Danisco A/S (Denmark)
- Genencor International, Inc. (US)
- Kinetic Biosystems, Inc. (US)
- Maxygen, Inc. (US)
- Codexis Inc. (US)
- Novozymes A/S (Denmark)
- Seravac Biotech (Pty) Ltd. (South Africa)
- Specialty Enzymes & Biotechnologies Co. (US)
- Verenium Corporation (US)
12. GLOBAL MARKET PERSPECTIVE
- Table 2: World Recent Past, Current & Future Analysis for Specialty
Enzymes by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific
(excluding Japan), Middle East,and Latin America Markets Independently
Analyzed withAnnual Sales Figures in US$ Million for Years 2007through 2015
(includes corresponding Graph/Chart)
- Table 3: World Historic Review for Specialty Enzymesby Geographic
Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Middle
East, andLatin America Markets Independently Analyzed withAnnual Sales Figures
in US$ Million for Years 2000through 2006 (includes corresponding
Graph/Chart)
- Table 4: World 11-Year Perspective for Specialty Enzymesby Geographic
Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe,
Asia-Pacific(excluding Japan), Middle East, and Latin AmericaMarkets for Years
2005, 2010 & 2015 (includescorresponding Graph/Chart)
- Table 5: World Recent Past, Current & Future Analysis for Specialty
Medical Enzymes by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific
(excluding Japan),Middle East, and Latin America Markets IndependentlyAnalyzed
with Annual Sales Figures in US$ Millionfor Years 2007 through 2015
(includescorresponding Graph/Chart)
- Table 6: World Historic Review for Specialty Medical Enzymesby
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed with Annual
Sales Figuresin US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart)
- Table 7: World 11-Year Perspective for Specialty Medical Enzymes by
Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan,
Europe,Asia-Pacific (excluding Japan), Middle East, andLatin America Markets
for Years 2005, 2010 & 2015(includes corresponding Graph/Chart)
- Table 8: World Recent Past, Current & Future Analysis for Polymerases
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, andLatin America Markets Independently Analyzed
withAnnual Sales Figures in US$ Million for Years 2007through 2015 (includes
corresponding Graph/Chart)
- Table 9: World Historic Review for Polymerases byGeographic Region -
US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Middle East,
andLatin America Markets Independently Analyzed withAnnual Sales Figures in
US$ Million for Years 2000through 2006 (includes corresponding Graph/Chart)
- Table 10: World 11-Year Perspective for Polymerases by Geographic
Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe,
Asia-Pacific(excluding Japan), Middle East, and Latin AmericaMarkets for Years
2005, 2010 & 2015 (includescorresponding Graph/Chart)
- Table 11: World Recent Past, Current & Future Analysisfor Nucleases by
Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding
Japan),Middle East, and Latin America Markets IndependentlyAnalyzed with
Annual Sales Figures in US$ Millionfor Years 2007 through 2015
(includescorresponding Graph/Chart)
- Table 12: World Historic Review for Nucleases by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and
Latin America Markets Independently Analyzed with Annual Sales Figures in US$
Million forYears 2000 through 2006 (includes correspondingGraph/Chart)
- Table 13: World 11-Year Perspective for Nucleases by Geographic Region
- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for
Years 2005,2010 & 2015 (includes corresponding Graph/Chart)
- Table 14: World Recent Past, Current & Future Analysisfor Other
Specialty Enzymes by Geographic Region -US, Canada, Japan, Europe,
Asia-Pacific (excludingJapan), Middle East, and Latin America
MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for
Years 2007 through 2015(includes corresponding Graph/Chart)
- Table 15: World Historic Review for Other Specialty Enzymesby
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed with Annual
Sales Figuresin US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart)
- Table 16: World 11-Year Perspective for Other SpecialtyEnzymes by
Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and Latin AmericaMarkets
for Years 2005, 2010 & 2015 (includescorresponding Graph/Chart)
- Table 17: World Recent Past, Current & Future Analysis for Specialty
Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US,
Canada, Japan,Europe, Asia-Pacific (excluding Japan), Middle East, andLatin
America Markets Independently Analyzed with AnnualSales Figures in US$ Million
for Years 2007 through 2015 (includes corresponding Graph/Chart)
- Table 18: World Historic Review for Specialty Enzymes Consumption in
Pharmaceuticals & Diagnostics byGeographic Region- US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$Million for Years 2000
through 2006 (includescorresponding Graph/Chart)
- Table 19: World 11-Year Perspective for Specialty Enzymes Consumption
in Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East,and Latin America Markets for Years 2005, 2010 & 2015(includes
corresponding Graph/Chart)
- Table 20: World Recent Past, Current & Future Analysis for Specialty
Enzymes Consumption in Research/Biotechnologyby Geographic Region- US, Canada,
Japan, Europe,Asia-Pacific (excluding Japan), Middle East, andLatin America
Markets Independently Analyzed withAnnual Sales Figures in US$ Million for
Years 2007through 2015 (includes corresponding Graph/Chart)
- Table 21: World Historic Review for SpecialtyEnzymes Consumption in
Research/Biotechnology byGeographic Region- US, Canada, Japan,
Europe,Asia-Pacific (excluding Japan), Middle East, andLatin America Markets
Independently Analyzed withAnnual Sales Figures in US$ Million for Years
2000through 2006 (includes correspondingGraph/Chart)
- Table 22: World 11-Year Perspective for Specialty Enzymes Consumption
in Research/Biotechnology by GeographicRegion - Percentage Breakdown of Dollar
Sales for US,Canada, Japan, Europe, Asia-Pacific (excluding Japan),Middle
East, and Latin America Markets forYears 2005, 2010 & 2015 (includes
correspondingGraph/Chart)
- Table 23: World Recent Past, Current & Future Analysis for Specialty
Enzymes Consumption in Other End-Use Segmentsby Geographic Region- US, Canada,
Japan, Europe,Asia-Pacific (excluding Japan), Middle East, andLatin America
Markets Independently Analyzed withAnnual Sales Figures in US$ Million for
Years 2007through 2015 (includes corresponding Graph/Chart)
- Table 24: World Historic Review for SpecialtyEnzymes Consumption in
Other End-Use Segmentsby Geographic Region- US, Canada, Japan,
Europe,Asia-Pacific (excluding Japan), Middle East, andLatin America Markets
Independently Analyzed withAnnual Sales Figures in US$ Million for Years
2000through 2006 (includes corresponding Graph/Chart)
- Table 25: World 11-Year Perspective for SpecialtyEnzymes Consumption in
Other End-Use Segments byGeographic Region - Percentage Breakdown of
DollarSales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan),
Middle East, and Latin AmericaMarkets for Years 2005, 2010 & 2015(includes
correspondingGraph/Chart)
13. THE UNITED STATES
- A. Market Analysis
- Current and Future Analysis
- Competitive Scenario
- Table 26: Leading Players in the US Enzyme Market (2008):
Percentage Breakdown of Value Sales for Novozymes, Danisco, Allergan,
Genzyme,Genentech, and Others (includescorresponding Graph/Chart)
- Market Dynamics
- Specialty Enzymes Market is Projected to Rise
- Specialty Enzymes Form the Leading EnzymesSegment
- Pharmaceuticals and Diagnostics Continueto be the Largest Market
- Specialty Medical Enzymes in a Myriad of NovelApplications
- Market for Enzymes in Biotechnology
- B. Market Analytics
- Table 27: US Recent Past, Current & Future Analysisfor Specialty
Enzymes by Product Segment - SpecialtyMedical Enzymes, Polymerases,
Nucleases andOther Enzymes Markets Independently Analyzedwith Annual Sales
Figures in US$ Million forYears 2007 through 2015 (includescorresponding
Graph/Chart)
- Table 28: US Historic Review for Specialty Enzymes by Product Segment
- Specialty Medical Enzymes,Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figuresin US$ Million for Years
2000 through 2006(includes corresponding Graph/Chart)
- Table 29: US 11-Year Perspective for Specialty Enzymesby Product
Segment - Percentage Breakdown ofDollar Sales for Specialty Medical
Enzymes,Polymerases, Nucleases and Other EnzymesMarkets for 2005, 2010 &
2015 (includescorresponding Graph/Chart)
- Table 30: US Recent Past, Current & Future Analysisfor Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnologyand Others Markets Independently Analyzedwith Annual
Sales Figures in US$ Million forYears 2007 through 2015
(includescorresponding Graph/Chart)
- Table 31: US Historic Review for SpecialtyEnzymes by End-Use Segment
- Pharmaceuticals & Diagnostics, Research/Biotechnology and OthersMarkets
Independently Analyzed with Annual SalesFigures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart)
- Table 32: US 11-Year Perspective for SpecialtyEnzymes by End-Use
Segment - PercentageBreakdown of Dollar Sales for Pharmaceuticals &
Diagnostics, Research/Biotechnology and OthersMarkets for 2005, 2010 & 2015
(includescorresponding Graph/Chart)
14. CANADA
- Market Analysis
- Table 33: Canadian Recent Past, Current & FutureAnalysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleasesand Other Enzymes Markets Independently Analyzedwith
Annual Sales Figures in US$ Million for Years2007 through 2015(includes
correspondingGraph/Chart)
- Table 34: Canadian Historic Review forSpecialty Enzymes by Product
Segment - SpecialtyMedical Enzymes, Polymerases, Nucleases andOther Enzymes
Markets Independently Analyzedwith Annual Sales Figures in US$ Million
forYears 2000 through 2006 (includescorresponding Graph/Chart)
- Table 35: Canadian 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart)
- Table 36: Canadian Recent Past, Current & FutureAnalysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research /Biotechnology and Others Markets IndependentlyAnalyzed with Annual
Sales Figures in US$ Millionfor Years 2007 through 2015
(includescorresponding Graph/Chart)
- Table 37: Canadian Historic Review for Specialty Enzymes by End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for
Years 2000 through 2006(includes corresponding Graph/Chart)
- Table 38: Canadian 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015
(includes correspondingGraph/Chart)
15. JAPAN
- Market Analysis
- Table 39: Japanese Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 40: Japanese Historic Review for Specialty Enzymesby Product
Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales Figuresin US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 41: Japanese 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
Enzymes,Polymerases, Nucleases and Other EnzymesMarkets for 2005, 2010 &
2015 (includescorresponding Graph/Chart)
- Table 42: Japanese Recent Past, Current & FutureAnalysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnologyand Others Markets Independently Analyzed withAnnual
Sales Figures in US$ Million for Years 2007through 2015 (includes
corresponding Graph/Chart)
- Table 43: Japanese Historic Review for Specialty Enzymesby End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor
Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 44: Japanese 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics,Research / Biotechnology and Others Markets for 2005,2010 & 2015
(includes corresponding Graph/Chart)
16. EUROPE
- Market Analysis
- Table 45: European Recent Past, Current & Future Analysisfor
Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed with Annual
SalesFigures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 46: European Historic Review for Specialty Enzymes by
Geographic Region - France, Germany, Italy, UK,Spain, Russia, and Rest of
Europe Markets Independently Analyzed with Annual Sales Figures in US$
Millionfor Years 2000 through 2006 (includescorresponding Graph/Chart)
- Table 47: European 11-Year Perspective for Specialty Enzymes by
Geographic Region - Percentage Breakdownof Dollar Sales for France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2005,2010 &
2015 (includes corresponding Graph/Chart)
- Table 48: European Recent Past, Current & FutureAnalysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleasesand Other Enzymes Markets Independently Analyzedwith
Annual Sales Figures in US$ Million forYears 2007 through 2015
(includescorresponding Graph/Chart)
- Table 49: European Historic Review for SpecialtyEnzymes by Product
Segment - Specialty MedicalEnzymes, Polymerases, Nucleases and OtherEnzymes
Markets Independently Analyzed withAnnual Sales Figures in US$ Million
forYears 2000 through 2006 (includescorresponding Graph/Chart)
- Table 50: European 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
EnzymesPolymerases, Nucleases and Other EnzymesMarkets for 2005, 2010 & 2015
(includescorresponding Graph/Chart)
- Table 51: European Recent Past, Current & FutureAnalysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnologyand Others Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through2015 (includes
corresponding Graph/Chart)
- Table 52: European Historic Review for Specialty Enzymes by End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor
Years 2000 through 2006 (includescorresponding Graph/Chart)
- Table 53: European 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015
(includes correspondingGraph/Chart)
16a. FRANCE
- Market Analysis
- Table 54: French Recent Past, Current & FutureAnalysis for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleasesand Other Enzymes Markets Independently Analyzedwith Annual Sales
Figures in US$ Millionfor Years 2007 through 2015 (includescorresponding
Graph/Chart)
- Table 55: French Historic Review for Specialty Enzymesby Product
Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales Figuresin US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 56: French 11-Year Perspective for SpecialtyEnzymes by Product
Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
Enzymes,Polymerases, Nucleases and Other EnzymesMarkets for 2005, 2010 &
2015 (includescorresponding Graph/Chart)
- Table 57: French Recent Past, Current & FutureAnalysis for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets IndependentlyAnalyzed with Annual
Sales Figures in US$ Millionfor Years 2007 through 2015
(includescorresponding Graph/Chart)
- Table 58: French Historic Review for Specialty Enzymesby End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor
Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 59: French 11-Year Perspective for SpecialtyEnzymes by End-Use
Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015
(includes correspondingGraph/Chart)
16b. GERMANY
- Market Analysis
- Table 60: German Recent Past, Current & Future Analysis for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed with AnnualSales
Figures in US$ Million for Years 2007 through2015 (includes corresponding
Graph/Chart)
- Table 61: German Historic Review for Specialty Enzymesby Product
Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales Figuresin US$
Million for Years 2000 through 2006(includes corresponding Graph/Chart)
- Table 62: German 11-Year Perspective for SpecialtyEnzymes by Product
Segment - Percentage Breakdownof Dollar Sales for Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart)
- Table 63: German Recent Past, Current & Future Analysis for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and OthersMarkets Independently Analyzed with Annual
SalesFigures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 64: German Historic Review for Specialty Enzymesby End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
Markets Independently Analyzed with Annual Sales Figures in US$ Million
forYears 2000 through 2006 (includes corresponding Graph/Chart)
- Table 65: German 11-Year Perspective for SpecialtyEnzymes by End-Use
Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for 2005,2010 & 2015
(includes corresponding Graph/Chart)
16c. ITALY
- Market Analysis
- Table 66: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with
Annual SalesFigures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 67: Italian Historic Review for Specialty Enzymesby Product
Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales Figures inUS$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 68: Italian 11-Year Perspective for SpecialtyEnzymes by Product
Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
Enzymes,Polymerases, Nucleases and Other EnzymesMarkets for 2005, 2010 &
2015 (includescorresponding Graph/Chart)
- Table 69: Italian Recent Past, Current & FutureAnalysis for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnologyand Others Markets Independently Analyzedwith Annual
Sales Figures in US$ Million forYears 2007 through 2015
(includescorresponding Graph/Chart)
- Table 70: Italian Historic Review for Specialty Enzymesby End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others
MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for
Years 2000 through 2006(includes corresponding Graph/Chart)
- Table 71: Italian 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 &2015
(includes corresponding Graph/Chart)
16d. THE UNITED KINGDOM
- Market Analysis
- Table 72: UK Recent Past, Current & Future Analysis for Specialty
Enzymes by Product Segment - SpecialtyMedical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes corresponding
Graph/Chart)
- Table 73: UK Historic Review for Specialty Enzymes by Product Segment
- Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes
Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor
Years 2000 through 2006 (includescorresponding Graph/Chart)
- Table 74: UK 11-Year Perspective for Specialty Enzymes by Product
Segment - Percentage Breakdown of Dollar Salesfor Specialty Medical Enzymes,
Polymerases, Nucleasesand Other Enzymes Markets for 2005, 2010 &
2015(includes corresponding Graph/Chart)
- Table 75: UK Recent Past, Current & Future Analysis for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently Analyzed with Annual
Sales Figures inUS$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 76: UK Historic Review for Specialty Enzymes by End-Use Segment
- Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets
IndependentlyAnalyzed with Annual Sales Figures in US$ Millionfor Years 2000
through 2006 (includescorresponding Graph/Chart)
- Table 77: UK 11-Year Perspective for Specialty Enzymes by End-Use
Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015
(includes corresponding Graph/Chart)
16e. SPAIN
- Market Analysis
- Table 78: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 79: Spanish Historic Review for Specialty Enzymesby Product
Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales Figures inUS$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 80: Spanish 11-Year Perspective for SpecialtyEnzymes by Product
Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
Enzymes,Polymerases, Nucleases and Other EnzymesMarkets for 2005, 2010 &
2015(includescorresponding Graph/Chart)
- Table 81: Spanish Recent Past, Current & FutureAnalysis for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnologyand Others Markets Independently Analyzed withAnnual
Sales Figures in US$ Million for Years 2007through 2015(includes
corresponding Graph/Chart)
- Table 82: Spanish Historic Review for Specialty Enzymesby End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for
Years 2000 through 2006(includes corresponding Graph/Chart)
- Table 83: Spanish 11-Year Perspective for SpecialtyEnzymes by End-Use
Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015
(includes correspondingGraph/Chart)
16f. RUSSIA
- Market Analysis
- Table 84: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with
AnnualSales Figures in US$ Million for Years 2007 through2015 (includes
corresponding Graph/Chart)
- Table 85: Russian Historic Review for Specialty Enzymesby Product
Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales Figuresin US$
Million for Years 2000 through 2006(includes corresponding Graph/Chart)
- Table 86: Russian 11-Year Perspective for SpecialtyEnzymes by Product
Segment - Percentage Breakdown of Dollar Sales for Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart)
- Table 87: Russian Recent Past, Current & FutureAnalysis for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnologyand Others Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through2015 (includes
corresponding Graph/Chart)
- Table 88: Russian Historic Review for Specialty Enzymesby End-Use
Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others
MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for
Years 2000 through 2006(includes corresponding Graph/Chart)
- Table 89: Russian 11-Year Perspective for SpecialtyEnzymes by End-Use
Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics,Research / Biotechnology and Others Markets for2005, 2010 & 2015
(includes correspondingGraph/Chart)
16g. REST OF EUROPE
- Market Analysis
- Table 90: Rest of Europe Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleasesand Other Enzymes Markets Independently Analyzedwith
Annual Sales Figures in US$ Million for Years2007 through 2015 (includes
correspondingGraph/Chart)
- Table 91: Rest of Europe Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets Independently Analyzed with Annual Sales Figuresin US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 92: Rest of Europe 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart)
- Table 93: Rest of Europe Recent Past, Current &Future Analysis for
Specialty Enzymes by End-UseSegment - Pharmaceuticals & Diagnostics,
Research / Biotechnology and Others Markets IndependentlyAnalyzed with
Annual Sales Figures in US$ Millionfor Years 2007 through 2015
(includescorresponding Graph/Chart)
- Table 94: Rest of Europe Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology
and OthersMarkets Independently Analyzed with Annual SalesFigures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 95: Rest of Europe 11-Year Perspective forSpecialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and OthersMarkets for 2005, 2010 & 2015
(includescorresponding Graph/Chart)
17. ASIA-PACIFIC
- A. Market Analysis
- Current and Future Analysis
- Enzyme Market in China
- Enzyme Demand by End-Use
- Table 96: Chinese Enzyme Market (2009):Percentage Breakdown of
Dollar Demand byEnd-Use Market - Industrial (Food & Beverage, Cleaning
Products, Animal Feed, EthanolProduction, and Other Industrial) and
Specialty (includes corresponding Graph/Chart)
- Enzyme Demand by Enzyme Type
- Table 97: Chinese Enzyme Market (2009):Percentage Breakdown of
Dollar Demand byEnzyme Type - Carbohydrases (Amylases andOther
Carbohydrases), Proteases, Lipases,Polymerases & Nucleases, and Other
Enzymes(includes corresponding Graph/Chart)
- B. Market Analytics
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleasesand Other Enzymes Markets Independently Analyzedwith
Annual Sales Figures in US$ Million for Years2007 through 2015 (includes
correspondingGraph/Chart)
- Table 99: Asia-Pacific Historic Review for SpecialtyEnzymes by
Product Segment - Specialty MedicalEnzymes, Polymerases, Nucleases and
OtherEnzymes Markets Independently Analyzed withAnnual Sales Figures in US$
Million for Years2000 through 2006 (includes correspondingGraph/Chart)
- Table 100: Asia-Pacific 11-Year Perspective forSpecialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for Specialty
MedicalEnzymes, Polymerases, Nucleases and OtherEnzymes Markets for 2005,
2010 & 2015(includes corresponding Graph/Chart)
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research /Biotechnology and Others Markets IndependentlyAnalyzed with Annual
Sales Figures in US$ Millionfor Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 102: Asia-Pacific Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology
and OthersMarkets Independently Analyzed with Annual SalesFigures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 103: Asia-Pacific 11-Year Perspective forSpecialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and OthersMarkets for 2005, 2010 & 2015
(includescorresponding Graph/Chart)
18. THE MIDDLE EAST
- Market Analysis
- Table 104: Middle East Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 105: Middle East Historic Review for Specialty Enzymes by
Product Segment - Specialty MedicalEnzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual SalesFigures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 106: Middle East 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdownof Dollar Sales for Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart)
- Table 107: Middle East Recent Past, Current &Future Analysis for
Specialty Enzymes byEnd-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others MarketsIndependently Analyzed with Annual
Sales Figuresin US$ Million for Years 2007 through 2015(includes
corresponding Graph/Chart)
- Table 108: Middle East Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and
OthersMarkets Independently Analyzed with Annual SalesFigures in US$ Million
for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 109: Middle East 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdownof Dollar Sales for Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets for 2005,2010 & 2015
(includes corresponding Graph/Chart)
19. LATIN AMERICA
- Market Analysis
- Table 110: Latin American Recent Past, Current &Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleasesand Other Enzymes Markets Independently Analyzedwith
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 111: Latin American Historic Review for Specialty Enzymes by
Product Segment - Specialty MedicalEnzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual SalesFigures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 112: Latin American 11-Year Perspective forSpecialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for Specialty
MedicalEnzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005,
2010 & 2015 (includescorresponding Graph/Chart)
- Table 113: Latin American Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/ Biotechnology and Others Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart)
- Table 114: Latin American Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and
OthersMarkets Independently Analyzed with Annual SalesFigures in US$ Million
for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 115: Latin American 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets
for 2005, 2010 &2015 (includes corresponding Graph/Chart)
COMPETITION
|
 |
